Antiparasitic Drugs Global Market Report 2022: Government, Non-Profit and Market Player Initiatives to Boost Adoption Bode Well For Growth - ResearchAndMarkets.com
Retrieved on:
Friday, November 4, 2022
Health, Pharmaceutical, Product type, Route of administration, Chagas disease, Animal, Novartis, Malaria, Leishmaniasis, Infection, CAGR, Industry, Region, Trypanocidal agent, Parasitism, Merck Group, Aurobindo Pharma, Sun Pharma, Application, GlaxoSmithKline, Marketing, Lupinus, Cadila Pharmaceuticals, Viatris, US, Amazon Malaria Initiative, Wickham Laboratories Ltd, PMI, Administration, Renewable energy, Pharmaceutical industry, Protozoa, Parasitic worm
These infections result from parasites, which are tiny organisms that live on or inside people and animals.
Key Points:
- These infections result from parasites, which are tiny organisms that live on or inside people and animals.
- There are various antiparasitic drugs, each drug targets a specific parasite.
- Antiparasitic drugs treat several kinds of infections that result from a thousand types of parasites.
- This would in turn increase demand for antiparasitic drugs and hence fuel growth of the global antiparasitic drugs market over the forecast period.